The Oncology Institute: Making Progress [Seeking Alpha]
The Oncology Institute, Inc. (TOI)
Company Research
Source: Seeking Alpha
TOI raised FY25 guidance to $500M revenue and expects positive Adj. EBITDA in Q4, with cash flow positivity likely by mid-2026. Despite a massive share price surge in 12 months, GAAP EPS profitability remains two years away; consolidation is expected before a favorable entry point. An analysis of The Oncology Institute follows in the paragraphs below. adamkaz/E+ via Getty Images Shares of cancer care and cost management solutions provider The Oncology Institute, Inc. ( TOI rallied some since November 14, 2025 after signs of imminent profitability in its 3Q25 report. In addition to generating a 37% improvement at the More on my IG service Live Chat on The Biotech Forum sees frequent discussion of specific covered call trades. To see what covered call trades I am currently executing along with a model portfolio of attractive biotech stocks, just initiate your free trial into The Biotech Forum by clicking HERE This article was written by Analyst's Disclosure: I/we have a
Show less
Read more
Impact Snapshot
Event Time:
TOI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TOI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TOI alerts
High impacting The Oncology Institute, Inc. news events
Weekly update
A roundup of the hottest topics
TOI
News
- The Oncology Institute Announces Resignation of Board Member Gabe Ling [Yahoo! Finance]Yahoo! Finance
- The Oncology Institute Announces Resignation of Board Member Gabe LingGlobeNewswire
- Oncology Institute (NASDAQ:TOI) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $5.00 price target on the stock.MarketBeat
- The Oncology Institute, Inc. (TOI) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Earnings To Watch: The Oncology Institute Inc (TOI) Reports Q3 2025 Result [Yahoo! Finance]Yahoo! Finance
TOI
Earnings
- 11/13/25 - Miss
TOI
Sec Filings
- 12/16/25 - Form 4
- 12/15/25 - Form 144
- 12/1/25 - Form 4
- TOI's page on the SEC website